A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration
Author:
Affiliation:
1. New York Blood Center
2. Department of Pathology
3. Department of Medicine; New York-Presbyterian Hospital; New York New York
Publisher
Wiley
Subject
Hematology,Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.13076/fullpdf
Reference36 articles.
1. Hematopoietic stem cell mobilization: updated conceptual renditions;Bonig;Leukemia,2013
2. Plerixafor added to chemotherapy plus G-CSF is safe and allows adequate PBSC collection in predicted poor mobilizer patients with multiple myeloma or lymphoma;Attolico;Biol Blood Marrow Transplant,2012
3. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma;DiPersio;J Clin Oncol,2009
4. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma;DiPersio;Blood,2009
5. Factors that influence collection and engraftment of autologous peripheral-blood stem cells;Bensinger;J Clin Oncol,1995
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Outcomes of upfront plerixafor use for mobilization in germ cell tumor patients;Hematology, Transfusion and Cell Therapy;2024-03
2. Potentially modifiable predictors of cell collection efficiencies and product characteristics of allogeneic hematopoietic progenitor cell collections;Transfusion;2021-03-13
3. Optimizing leukapheresis product yield and purity for blood cell-based gene and immune effector cell therapy;Current Opinion in Hematology;2020-09-14
4. CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent;Pharmacological Research;2020-09
5. High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma;Bone Marrow Transplantation;2019-06-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3